Pages with the fewest revisions

From NeuroRehab.wiki

Showing below up to 50 results in range #101 to #150.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. DECONDITIONING-RESPIRATORY EFFECTS‏‎ (1 revision)
  2. PAIN-DOCUMENTATION‏‎ (1 revision)
  3. MYASTHENIA GRAVIS-INVESTIGATIONS‏‎ (1 revision)
  4. BLADDER-ADVANTAGES OF IDC‏‎ (1 revision)
  5. SPASTICITY-DANTROLENE‏‎ (1 revision)
  6. CLINICAL-CAUSES OF KORSAKOFF'S PSYCHOSIS‏‎ (1 revision)
  7. PAIN-NSAID SIDE EFFECTS‏‎ (1 revision)
  8. NCS-ALGORITHM‏‎ (1 revision)
  9. BLADDER-MORBIDITY‏‎ (1 revision)
  10. GAIT-CENTRE OF GRAVITY‏‎ (1 revision)
  11. SPASTICITY-PATHOPHYSIOLOGY‏‎ (1 revision)
  12. AMBULATION AIDS-CANADIAN CRUTCHES‏‎ (1 revision)
  13. DEMENTIA-BPSD NON-PHARMACOLOGICAL MGM‏‎ (1 revision)
  14. CLINICAL-CHARACTERISTICS OF SUPRANUCLEAR PALSY‏‎ (1 revision)
  15. SUBMANDIBULAR GANGLION-BRANCHES‏‎ (1 revision)
  16. PAIN-RELATED LEARNING FACTORS‏‎ (1 revision)
  17. NCS-EMG (ABNORMAL RESTING MOTOR UNIT ACTIVITY)‏‎ (1 revision)
  18. LYMPHEDEMA-CHRONIC OEDEMA CAUSES‏‎ (1 revision)
  19. BRACHIAL PLEXUS INJURY-MANAGEMENT GOALS‏‎ (1 revision)
  20. GAIT ALIGNMENT-INTERNALLY ROTATED FOOT‏‎ (1 revision)
  21. SPINAL CORD INJURY-PROGNOSIS (PARAPLEGIA)‏‎ (1 revision)
  22. AMPUTATION-OSSEOINTEGRATION ADVANTAGES‏‎ (1 revision)
  23. PVD-CAROTID ARTERY DISEASE‏‎ (1 revision)
  24. DEMENTIA-VASCULAR VS. ALZHEIMER'S‏‎ (1 revision)
  25. CLINICAL-LIGHT TOUCH TESTING‏‎ (1 revision)
  26. PAIN-VERTEBROPLASTY CONTRAINDICATIONS‏‎ (1 revision)
  27. NCS-SENSORY TESTING PARAMETERS‏‎ (1 revision)
  28. CANCER REHABILITATION-BRAIN TUMOR MEDICAL MGM‏‎ (1 revision)
  29. SPINA BIFIDA-OPEN TUBE DEFECTS‏‎ (1 revision)
  30. AMPUTATION-TFA SUSPENSION OPTIONS‏‎ (1 revision)
  31. DERMATOMES-L1 TO L3‏‎ (1 revision)
  32. CLINICAL-PULSE CHARACTERISTICS‏‎ (1 revision)
  33. PARKINSONS & PARKINSONISM-MANAGEMENT (NEWER MODALITIES)‏‎ (1 revision)
  34. NEUROGENIC BOWEL-LONG TERM MANAGEMENT‏‎ (1 revision)
  35. CAPACITY-STEP 3. REASONING‏‎ (1 revision)
  36. AMPUTEE SELECTION-PSYCHOLOGICAL ASSESSMENT‏‎ (1 revision)
  37. DIABETES MELLITUS-COMPLICATIONS‏‎ (1 revision)
  38. TBI-AGGRESSION OR AGITATION MEDICATIONS‏‎ (1 revision)
  39. PARKINSONS (MILD TO MODERATE) Tx-DOPAMINE AGONISTS‏‎ (1 revision)
  40. NEUROPATHY-ALGORITHM‏‎ (1 revision)
  41. CARDIAC INX-CARDIAC BIOPSY‏‎ (1 revision)
  42. SPINE IMAGING-LUMBAR OBLIQUE PROJECTION‏‎ (1 revision)
  43. ANKLE BRACHIAL INDEX (ABI)‏‎ (1 revision)
  44. DIABETES MELLITUS-PRE DIABETES INX‏‎ (1 revision)
  45. CN III (OCCULOMOTOR)-B. ORIGIN‏‎ (1 revision)
  46. TBI-GENERAL COGNITIVE (PHARMACOLOGIC) MGM‏‎ (1 revision)
  47. PHAEOCHROMOCYTOMA-RISK FACTORS‏‎ (1 revision)
  48. NEUROPATHY-PARAPROTEINAEMIA‏‎ (1 revision)
  49. MND-DRIVING‏‎ (1 revision)
  50. GRAVES DISEASE-SURGICAL MGM‏‎ (1 revision)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)